Across TCGA pan-cancer cohorts, LINC02573 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02573’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02573 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02573 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
COAD and KIRC are the cancer types where LINC02573 tumor–normal differential expression is most reproducible.